STOCKS TELEGRAPH

Tag: SNES

  • SenesTech, Inc. (SNES) Stock Surge Following Continued Proliferation of ContraPest

    SenesTech, Inc. (SNES) stock prices were up by 4.40% as of the market closing on June 25th, 2021, bringing the price per share up to USD$1.66 at the end of the trading day. Subsequent pre-market fluctuations saw the stock surge by another 7.23%, bringing it up to USD$1.78.

    New Brand Campaign

    May 2021 saw the company launch a new brand campaign, The Pest Control Difference, with its proprietary ContraPest at the forefront. The rebranding of the company’s image comes in line with its transition from a science-based research company to a solutions based commercial company. SNES is keen to highlight its environmental responsibility as it provides an innovative and effective tool for pest control management in the 21st century.

    ContraPest

    March 2021 saw the company complete model agricultural deployments of ContraPest, which had a proven track record of successfully reducing rodent populations and, consequently, improving operating economies in poultry settings. A measurable reduction in rodent populations was reported within six months of deployment at both an eff production farm and a pullet house. Within a year of adding ContraPest, the egg farm reported a 95% decline in rodent activity.

    ContraPest Success

    The company also reported a long-term deployment that was completed in March 2021, with the East Coast urban setting reporting highly promising results. Data from the twelfth month showed a 94% reduction in rat activity at Site A, as well as a 98% reduction in juvenile rat photos since the start of monitoring. Site B reported a 99% reduction in rodent activity, with a 100% reduction in juvenile rat photos during the same period.

    Scope of ContraPest

    As of January 1st, 2021, California’s AB1788 bill was signed by the Governor and became law. The California Ecosystems Protection Act from 2020 will accordingly result in the prohibition of the four main SGAR’s used to treat rodent pest control problems. With ContraPest being a viable alternative, this development has seen a market space open up for SNES that could amount to a potential USD$100 million every year.

    Solid Financials

    Revenue for the first quarter of the fiscal year 2021 was reported at USD$88,000, up from the USD$37,000 reported in the same quarter of the prior year. The 138% year-over-year increase is not inclusive of more than USD$20,000 of backlog, with late orders fulfilled in April 2021 being included in the second quarter of 2021’s numbers. As of the end of Q1 2021, SNES reported a solid liquidity position of USD$15.2 million.

    Future Outlook for SNES

    Armed with a solid liquidity position, SNES is poised to capitalize on the proliferation of its ContraPest technology. Current and potential investors are hopeful that management will continue to leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

  • SenesTech Inc. (SNES) stock rises during pre-market trading session. Here’s what’s happening?

    SenesTech Inc. (SNES) stock rises during pre-market trading session. Here’s what’s happening?

    SenesTech Inc. (NASDAQ: SNES) stock gained by 12.50% in the last trading close while the SNES stock keeps on rising by 2.02% during the pre-market trading session after SenesTech announced its collaboration with Liphatech. SenesTech is an agricultural biotechnology company that focuses on the management of fertility for pest control through different technologies. ContraPest is their first commercial which works to fight difficult rat outbreak.

    What’s happening?

    The purpose of collaboration between SenesTech and Liphatech is to develop a non-liquid formulation of ContraPest. Both SenesTech and Liphatech which is an internationally known researcher and distributor of unique and effective pest control products will equally participate to the project through providing resources and finances.

    ContraPest is a rat birth control product. Also it not just only eliminates rat infestations, but it also prevents them from returning. ContraPest has proven to be effective in reducing rat populations over the course of five years of research and implementation in municipal, agricultural, and commercial settings. ContraPest is currently available in a liquid formulation that has been approved by the Environmental Protection Agency.

    Furthermore,

    Brandy Pyzyna, the VP of SeneTech’s Research and Regulatory department said that their area of work will be comprised of all preparation, implementation, and testing to check the efficiency of the non-liquid formulation of ContraPest which is based on the soft bait matrix developed and advertised by Liphatech. Brandy also added that they have a comprehensive, collaborative work plan in place that they can implement right away.

    Conclusion

    This recent positive development in SenesTech has possibly acted as a great initiative for the progress of SNES. Also it has brought the focus of Investors towards the SNES stock. In the past as well, SenesTech through its ContraPest brand has shown great beneficial results whenever it has been linked with any Pest control program. Hence the expectations are high from this collaboration as well.

  • Here is why SenesTech Inc. (SNES) stock is skyrocketing in Friday’s Pre-market

    Here is why SenesTech Inc. (SNES) stock is skyrocketing in Friday’s Pre-market

    SenesTech Inc. (SNES) stock is soaring in Friday’s 19th March Pre-market session. As of this writing, it has gained 61.31%. Let’s try to findout what’s the reason behind pre-market surge.

    Successful completion of a long-term agricultural deployment of ContraPest

    Yesterday, after market close, SNES announced the successful results of ContraPestagricultural deployments. It showed success in reducing rat populations and improving operating economies in poultry settings.

    ContraPest is the company’s first fertility control product,for managing animal pest populations.

    ContraPest was used at an egg production farm on the west coast, where cameras were used to monitor the rat populations over a year. A reduction in rat activity was noted throughout ContraPest treatment. Over the year there was a 90% decline in rat activity.

    On a second pullet farm on the east coast, economic impacts and consumption rates caused by rats were recorded before and after the introduction of ContraPest.88% improvement in pullet survival after reducing their rat population with ContraPest.

    The CEO of SenesTechKen Siegel said that the results are immediately applicable to many other agricultural situations and ContraPest is now proven in the field to reduce infestations.

    Scheduling the release of Financial results

    On March 17, SNES said that SNES will report financial results for its fourth quarter and fiscal year 2020, ended December 31, 2020, after the market close on Thursday, March 25, 2021. SNES Stock has scheduled a conference call that same day, Thursday, March 25, 2021, at 5:00 pm ET, to review the results.

    About SNES

    SenesTech is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction. Senes Tech was founded by two scientists in 2003with a deep love for animals. SNES’s flagship product ContraPest is setting the new way for pest management, yielding proven and impressive results. ContraPest that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. SNES received EPA registration in 2016 and are currently registered in all 50 states and Washington D.C.

    Conclusion: The great results of ContraPest and the upcoming announcement of financial results is the main reason behind their pre-market rally. The positive trend for SNES stock can remain steady on the last day of the week.